Loading…

Impaired ankle‐brachial index in antiphospholipid syndrome: Beyond the traditional risk factors

Introduction The patients with antiphospholipid syndrome (APS) associate an increased risk of atherosclerosis. Objective To determine the predictors of an abnormal ankle‐brachial index (ABI), surrogate measure of atherosclerosis, in patients with APS. Methods The ABI was measured according to standa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical laboratory analysis 2019-01, Vol.33 (1), p.e22617-n/a
Main Authors: Caraiola, Simona, Jurcut, Ciprian, Dima, Alina, Jurcut, Ruxandra, Baicus, Cristian, Baicus, Anda
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction The patients with antiphospholipid syndrome (APS) associate an increased risk of atherosclerosis. Objective To determine the predictors of an abnormal ankle‐brachial index (ABI), surrogate measure of atherosclerosis, in patients with APS. Methods The ABI was measured according to standard recommendations in 106 patients. Traditional cardiovascular risk factors were assessed in all cases. A large spectrum of APS antibodies was determined in 73 patients. Results A total of 106 patients diagnosed with APS were included. 28.3% patients included were found to have low ABI. Anti‐beta 2‐glycoprotein I (aβ2GPI) IgG antibodies [4.00 (1.00‐79.00) vs 3.00 (0.00‐29.00) U/mL, P = 0.02] and antiprothrombin (aPT) IgM antibodies [4.50 (0.00‐82.00) vs 3.00 (0.00‐14.00) U/mL, P = 0.05] titers were found to be higher in patients with abnormal ABI. However, after multivariate regression analysis, only the aβ2GPI IgG titer remained predictor of low ABI (P = 0.04). Conclusions aβ2GPI IgG associated with impaired ABI in patients with APS. This relation might reflect their involvement in the atherosclerosis occurrence.
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.22617